Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OCTA Versus Structural OCT: Quantitative OCTA Biomarkers of Remission in Neovascular AMD

NCT03939195 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.

NCT NCT03939195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OCTA Versus Structural OCT: Quantitative OCTA Biomarkers of Remission in Neovascular AMD
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Observational
Overall status
Completed
Start date
December 1, 2018
Completion date
July 1, 2020
Enrollment
130 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration exudative eye left, macular degeneration exudative eye right